Pfizer CFO Dave Denton on Oncology, Obesity, and Pfizer’s Next Growth Cycle
Podcasts
•
32m
Pfizer CFO Dave Denton goes Inside the ICE House to discuss how the company is navigating its post‑COVID transition and positioning itself for a return to sustainable growth later this decade. He details Pfizer’s major strategic investments in oncology and metabolic health, including the Seagen and Metsera deals, and explains how proven platforms, global scale, and financial discipline are central to those moves. Denton also shares how execution, patient‑centric innovation, and emerging technologies like AI are shaping the next chapter of Pfizer’s growth story.
Up Next in Podcasts
-
Global X ETFs Pedro Palandrani on the...
Global X ETFs’ Pedro Palandrani goes Inside the ICE House to discuss the launch of the Global X NYSE 100 ETF and how it redefines innovation investing. He explains how the fund expands beyond traditional tech classifications to capture tech-enabled leaders across multiple sectors and exchanges us...
-
Ceasefire Relief, V‑Shaped Recovery +...
Eric Criscuolo, NYSE Market Strategist, recaps a sharp V‑shaped rally as markets rebounded from late‑March lows to push the S&P 500 to new record highs despite recent Middle East tensions. Falling oil prices, easing volatility, and renewed strength across mega‑cap tech, software, and higher‑risk ...
-
Capital Group Head of Product Holly F...
Holly Framsted, Head of Product at Capital Group, joins Bilal Little to discuss her unexpected journey into investing and her role leading product strategy at one of the world’s largest active asset managers. Framsted explains how Capital Group has expanded from zero to a large, fast-growing ETF ...
